Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of off-label rapamycin use to promote healthspan in 333 adults
Tammi L. Kaeberlein, Alan S. Green, George Haddad, et al.
GeroScience (2023) Vol. 45, Iss. 5, pp. 2757-2768
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Targeting ageing with rapamycin and its derivatives in humans: a systematic review
D. Lee, Ajla Hodzic Kuerec, Andrea B. Maier
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 2, pp. e152-e162
Open Access | Times Cited: 36
My battle with cancer. Part 1
Mikhail V. Blagosklonny
Oncoscience (2024) Vol. 11, pp. 1-14
Open Access | Times Cited: 8
The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals
Girish Harinath, Virginia Lee, Andy Nyquist, et al.
GeroScience (2025)
Open Access | Times Cited: 1
Gut microbiota and healthy longevity
Jia Luo, Shan Liang, Feng Jin
Science China Life Sciences (2024)
Closed Access | Times Cited: 6
Blazing a trail for the clinical use of rapamycin as a geroprotecTOR
Adam R. Konopka, Dudley W. Lamming, Brittany A. Grasso, et al.
GeroScience (2023) Vol. 45, Iss. 5, pp. 2769-2783
Open Access | Times Cited: 15
SGLT inhibitors for improving Healthspan and lifespan
James H. O’Keefe, Robert Weidling, Evan L. O’Keefe, et al.
Progress in Cardiovascular Diseases (2023) Vol. 81, pp. 2-9
Open Access | Times Cited: 15
Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumonia
Abhishek Singla, Nusrat Harun, Daniel F. Dilling, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 2, pp. 216-222
Closed Access | Times Cited: 5
Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension
Maarouf Baghdadi, Tobias Nespital, Carolina Monzó, et al.
Molecular Metabolism (2024) Vol. 81, pp. 101902-101902
Open Access | Times Cited: 5
An mTOR inhibitor discovery system using drug-sensitized yeast
Andrew Breen, Sarah Thomas, David Beckett, et al.
GeroScience (2025)
Open Access
Insulin-like Growth Factor-I Reduces Collagen Production by Hepatic Stellate Cells Through Stimulation of Collagen Degradation System via mTOR-Dependent Signaling Pathway
Takako Nishikawa, Natsuko Ohtomo, Yukiko Inoue, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 566-566
Open Access
Rapamycin does not compromise physical performance or muscle hypertrophy after PoWeR while intermittent rapamycin alleviates glucose disruptions by frequent rapamycin
Christian Elliehausen, Szczepan S. Olszewski, Carolyn G. Shult, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Macrophage Membrane Coated Manganese Dioxide Nanoparticles Loaded with Rapamycin Alleviate Intestinal Ischemia-Reperfusion Injury by Reducing Oxidative Stress and Enhancing Autophagy
Ren Sheng, Wei Wang, Weian Zeng, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3541-3557
Open Access
Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results
Mauricio Moel, Girish Harinath, Virginia Lee, et al.
Aging (2025)
Open Access
Autophagy and exosomes; inter-connected maestros in Alzheimer’s disease
Hanaa B. Atya, Nadia Mohamed Sharaf, Ragwa Mansour Abdelghany, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 2061-2073
Open Access | Times Cited: 4
Mikhail ‘Misha’ Blagosklonny’s enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin
David Barzilai
Aging (2025)
Open Access
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project
Amanda E. Coleman, Kate E. Creevy, Rozalyn M. Anderson, et al.
GeroScience (2025)
Closed Access
Elevated Levels of Plasma Phosphorylated Tau 181 (pTau181) Associated With Opioid Use to Guide Medication Titration Over a Clinically Relevant Short Timescale
Emily Hanson, Karl Berner, Jon Berner
Cureus (2025)
Open Access
Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
Mikhail V. Blagosklonny
Aging (2023) Vol. 15, Iss. 14, pp. 6632-6640
Open Access | Times Cited: 10
Safety and efficacy of rapamycin on healthspan metrics after one year: PEARL Trial Results
Girish Harinath, Virginia Lee, Andy Nyquist, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Geroprotector drugs and exercise: friends or foes on healthy longevity?
Christian Elliehausen, Rozalyn M. Anderson, Gary M. Diffee, et al.
BMC Biology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Solanum lycopersicum derived exosome-like nanovesicles alleviate restenosis after vascular injury through the Keap1/Nrf2 pathway
Hechen Shen, Meng Zhang, Dachang Liu, et al.
Food & Function (2024)
Open Access | Times Cited: 2
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies
Roberto Gambari, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1202-1202
Open Access | Times Cited: 4
Evaluation of off-label rapamycin use on oral health
Johnny Hudson, Tammi L. Kaeberlein, Akashdeep Mahal, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4135-4146
Open Access | Times Cited: 1
Microglial AKAP8L: a key mediator in diabetes-associated cognitive impairment via autophagy inhibition and neuroinflammation triggering
Wenyuan Zhang, Qianqian Wei, Tao Zhang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
The bioavailability of compounded and generic rapamycin in normative aging individuals: A retrospective study and review with clinical implications
Girish Harinath, Virginia Lee, Andy Nyquist, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top